![Pamela Keck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Keck
Investor Relations Contact chez
MEDIGENE AG
Profil
Ms. Pamela Keck is a VP, Head-IR & Corporate Communications at MediGene AG.
Ms. Keck was previously employed as a VP-Corporate Communications & Investor Relations by neurocare group AG.
Postes actifs de Pamela Keck
| Sociétés | Poste | Début |
|---|---|---|
| MEDIGENE AG | Investor Relations Contact | 01/02/2023 |
Anciens postes connus de Pamela Keck
| Sociétés | Poste | Fin |
|---|---|---|
neurocare group AG
 neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
neurocare group AG
neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Technology Services |
